Evidence map›Paper›PMID 30715980›Full record

ArticleHealth affairs (Project Hope)2019

Qualifying Conditions Of Medical Cannabis License Holders In The United States.

Kevin F Boehnke, Saurav Gangopadhyay, Daniel J Clauw, Rebecca L Haffajee

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Health affairs (Project Hope), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 107 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 5 pooled it
20.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 5 syntheses or guidelines pooled it, 224 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. ΔJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kevin F BoehnkeKevin F. Boehnke ( kboehnke@umich.edu ) is a research investigator in anesthesiology at the University of Michigan, in Ann Arbor.
Saurav GangopadhyaySaurav Gangopadhyay is a consultant at Deloitte in Chicago, Illinois.
Daniel J ClauwDaniel J. Clauw is a professor of anesthesiology, medicine, and psychiatry at the University of Michigan Medical School, in Ann Arbor.
Rebecca L HaffajeeRebecca L. Haffajee is an assistant professor of health management and policy, University of Michigan School of Public Health, in Ann Arbor.
University of Michigan–Ann Arbor · USDeloitte (United States) · US

Funding

Institutional Career Development CoreKL2TR002241 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELLINGROD, VICKI L · 2017 to 2021
$6.9M
University of Michigan's TMJD and Orofacial Pain Interdisciplinary ConsortiumK12DE023574 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CLAUW, DANIEL J, KAPILA, SUNIL D · 2013 to 2017
$1.8M
NCATS NIH HHS KL2 TR002241NIDCR NIH HHS K12 DE023574
6 · The paper itself

Abstract

The evidence for cannabis's treatment efficacy across different conditions varies widely, and comprehensive data on the conditions for which people use cannabis are lacking. We analyzed state registry data to provide nationwide estimates characterizing the qualifying conditions for which patients are licensed to use cannabis medically. We also compared the prevalence of medical cannabis qualifying conditions to recent evidence from the National Academies of Sciences, Engineering, and Medicine report on cannabis's efficacy in treating each condition. Twenty states and the District of Columbia had available registry data on patient numbers, and fifteen states had data on patient-reported qualifying conditions. Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (64.9 percent in 2016). Of all patient-reported qualifying conditions, 85.5 percent had either substantial or conclusive evidence of therapeutic efficacy. As medical cannabis use continues to increase, creating a nationwide patient registry would facilitate better understanding of trends in use and of its potential effectiveness.

Indexed as

CannabisChronic PainDistrict of ColumbiaHumansMedical MarijuanaRegistriesUnited StatesMedical Marijuana

Identifiers

PMID30715980
PMCPMC6398594
OpenAlexW2914697147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.